Escape from X chromosome inactivation and female bias of autoimmune diseases

Abstract Generally, autoimmune diseases are more prevalent in females than males. Various predisposing factors, including female sex hormones, X chromosome genes, and the microbiome have been implicated in the female bias of autoimmune diseases. During embryogenesis, one of the X chromosomes in the...

Full description

Saved in:
Bibliographic Details
Main Authors: Mohammad Javad Mousavi (Author), Mahdi Mahmoudi (Author), Somayeh Ghotloo (Author)
Format: Book
Published: BMC, 2020-12-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_4036dbe25b654328aa1818b65b3c1ab6
042 |a dc 
100 1 0 |a Mohammad Javad Mousavi  |e author 
700 1 0 |a Mahdi Mahmoudi  |e author 
700 1 0 |a Somayeh Ghotloo  |e author 
245 0 0 |a Escape from X chromosome inactivation and female bias of autoimmune diseases 
260 |b BMC,   |c 2020-12-01T00:00:00Z. 
500 |a 10.1186/s10020-020-00256-1 
500 |a 1076-1551 
500 |a 1528-3658 
520 |a Abstract Generally, autoimmune diseases are more prevalent in females than males. Various predisposing factors, including female sex hormones, X chromosome genes, and the microbiome have been implicated in the female bias of autoimmune diseases. During embryogenesis, one of the X chromosomes in the females is transcriptionally inactivated, in a process called X chromosome inactivation (XCI). This equalizes the impact of two X chromosomes in the females. However, some genes escape from XCI, providing a basis for the dual expression dosage of the given gene in the females. In the present review, the contribution of the escape genes to the female bias of autoimmune diseases will be discussed. 
546 |a EN 
690 |a Autoimmune diseases 
690 |a Escape genes 
690 |a Female bias 
690 |a X-chromosome inactivation 
690 |a Therapeutics. Pharmacology 
690 |a RM1-950 
690 |a Biochemistry 
690 |a QD415-436 
655 7 |a article  |2 local 
786 0 |n Molecular Medicine, Vol 26, Iss 1, Pp 1-20 (2020) 
787 0 |n https://doi.org/10.1186/s10020-020-00256-1 
787 0 |n https://doaj.org/toc/1076-1551 
787 0 |n https://doaj.org/toc/1528-3658 
856 4 1 |u https://doaj.org/article/4036dbe25b654328aa1818b65b3c1ab6  |z Connect to this object online.